Moleculin to Present at the 30th Annual ROTH Conference Tuesday, March 13, 2018
HOUSTON, TX--(Marketwired - March 06, 2018) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are …